Flucloxacillin and cefazolin for treatment of Staphylococcus aureus bloodstream infection.
Kirsten Schmidt-HellerauMarianne BreuningerJohanna KesselMaria Johanna Gobertina Tetuanui VehreschildGregor PaulJomana ReuschNorma JungMartin Gunnar HellmichGerd FätkenheuerPublished in: Infection (2024)
Using cefazolin rather than flucloxacillin as a first line agent for treatment of MSSA-BSI is supported by these clinical data.